tbuckley/cabot-search huggingface dataset:
How much time is necessary to assess maximal inspiratory pressure by unidirectional expiratory valve method in subjects without artificial airway
Authors: Samantha Grams, Karen Kimoto, Elen Azevedo, Christina Brito, Wellington Yamaguti
Journal: European Respiratory Journal (2014)

The most used method to evaluate maximal inspiratory pressure is by maintaining maximum negative pressure forced against an occluded airway (MIPsta). To overcome the need for collaboration during MIPsta, a new technique was developed using a unidirectional expiratory valve in patients undergoing invasive mechanical ventilation (MIPuni). For this evaluation, the occlusion should be maintained for at least 20 seconds to record maximal pressure. Recently, MIPuni has also been performed in subjects under spontaneous breathing without artificial airway. However, the necessary time to obtain MIPuni in subjects without artificial airway is still unknown. The aim of this study was to determine how much time is necessary to obtain MIPuni in subjects without artificial airway. Thirty-one subjects performed both MIPsta and MIPuni methods. For MIPuni, a digital vacuum manometer was attached to a unidirectional expiratory valve and a face mask for 20 seconds. During this period, all subjects were encouraged to make maximal respiratory efforts. To define the optimum duration of the maneuver, the 20 seconds of observation were partitioned every five-second interval (0-5s, 0-10s, 0-15s, 0-20s). MIPuni (117.3 ± 24.8 cmH2O; p<0.001) presented a statistically significant difference when compared to MIPsta (102.5 ± 23.9 cmH2O). Maximal peak values for MIPuni were achieved within the 20-second time window, which differed significantly from the peak values obtained during the 0-5s interval (p=0.036). We recommend that the occlusion should be maintained for at least 20 seconds to record MIPuni in subjects without artificial airway.
Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease
Authors: Ho-Young Yhim, Na Ri Lee, Eun-Kee Song, Chang-Yeol Yim, So Yeon Jeon, Bohee Lee, Jeong-A Kim, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak
Journal: Blood (2014)
Functional Definition of Progenitors Versus Mature Endothelial Cells Reveals Key SoxF-Dependent Differentiation Process
Authors: Jatin Patel, Elke J. Seppanen, Mathieu P. Rodero, Ho Yi Wong, Prudence Donovan, Zoltan Neufeld, Nicholas M. Fisk, Mathias Francois, Kiarash Khosrotehrani
Journal: Circulation (2016)

During adult life, blood vessel formation is thought to occur via angiogenic processes involving branching from existing vessels. An alternate proposal suggests that neovessels form from endothelial progenitors able to assemble the intimal layers. We here aimed to define vessel-resident endothelial progenitors in vivo in a variety of tissues in physiological and pathological situations such as normal aorta, lungs, and wound healing, tumors, and placenta, as well.Based on protein expression levels of common endothelial markers using flow cytometry, 3 subpopulations of endothelial cells could be identified among VE-Cadherin+ and CD45- cells.Lineage tracing by using Cdh5creERt2/Rosa-YFP reporter strategy demonstrated that the CD31-/loVEGFR2lo/intracellular endothelial population was indeed an endovascular progenitor (EVP) of an intermediate CD31intVEGFR2lo/intracellular transit amplifying (TA) and a definitive differentiated (D) CD31hiVEGFR2hi/extracellular population. EVP cells arose from vascular-resident beds that could not be transferred by bone marrow transplantation. Furthermore, EVP displayed progenitor-like status with a high proportion of cells in a quiescent cell cycle phase as assessed in wounds, tumors, and aorta. Only EVP cells and not TA and D cells had self-renewal capacity as demonstrated by colony-forming capacity in limiting dilution and by transplantation in Matrigel plugs in recipient mice. RNA sequencing revealed prominent gene expression differences between EVP and D cells. In particular, EVP cells highly expressed genes related to progenitor function including Sox9, Il33, Egfr, and Pdfgrα. Conversely, D cells highly expressed genes related to differentiated endothelium including Ets1&2, Gata2, Cd31, Vwf, and Notch. The RNA sequencing also pointed to an essential role of the Sox18 transcription factor. The role of SOX18 in the differentiation process was validated by using lineage-tracing experiments based on Sox18CreERt2/Rosa-YFP mice. Besides, in the absence of functional SOX18/SOXF, EVP progenitors were still present, but TA and D populations were significantly reduced.Our findings support an entirely novel endothelial hierarchy, from EVP to TA to D, as defined by self-renewal, differentiation, and molecular profiling of an endothelial progenitor. This paradigm shift in our understanding of vascular-resident endothelial progenitors in tissue regeneration opens new avenues for better understanding of cardiovascular biology.
Prolonged Administration of Arsenic Trioxide (Trisenox®) for Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) at MD Anderson Cancer Center: A Phase II Study.
Authors: Miloslav Beran, Srdan Verstovsek, Steven M. Kornblau, Elihu H. Estey, Francis Giles, Guillermo Garcia-Manero, Hagop M. Kantarjian
Journal: Blood (2004)
Autologous HSCT Followed By Immunotherapy and Maintenance Chemotherapy Compared with Allogeneic HSCT for Intermediate-Risk Molecules/Cytogenetics Acute Myeloblastic Leukemia in First Complete Remission
Authors: Xiao Zhai, Li Xuan, Jing Sun, Zhiping Fan, Yu Zhang, Fen Huang, Qianli Jiang, Dan Xu, Yongqiang Wei, Hongsheng Zhou, Qifa Liu
Journal: Blood (2014)
Association of Cyclophosphamide (CY) and Fludarabine (FLU) Pharmacokinetics with Treatment Related Mortality (TRM) after Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT)
Authors: Anthony C. Wiseman, Kinjal Sanghavi, Qing Cao, Erica D. Warlick, Claudio G Brunstein, John Rogosheske, Andy Kurtzweil, Daniel J. Weisdorf, Pamala A. Jacobson
Journal: Blood (2014)
Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function
Authors: Florian Perner, Felix C Saalfeld, Tina M Schnoeder, Denise Wolleschak, Corinna Fahldieck, Satish Ranjan, Berend H Isermann, Katrin Hebel, Monika Brunner-Weinzierl, Thomas Fischer, Florian H Heidel
Journal: Blood (2014)
Extreme Insulin Resistance From Insulin Antibodies (Not Insulin Receptor Antibodies) Successfully Treated With Combination Immunosuppressive Therapy
Authors: Jennifer B. Hao, Shahnawaz Imam, Pervaiz Dar, Maria Alfonso-Jaume, Noha Elnagar, Juan Carlos Jaume
Journal: Diabetes Care (2016)

A relationship between insulin resistance (IR) and insulin antibodies (IAs) was first described in the 1950s and was thought to be due to the use of nonhuman insulins (1). Since the introduction of human insulin, the presence of IAs and consequent IR was felt to be clinically insignificant (2).

The presence of high levels of IAs, associated with random hypoglycemia in insulin-naive patients, is termed insulin autoimmune syndrome or Hirata disease (3,4). In some cases, postprandial hyperglycemia (insulin bound to antibody) and fasting hypoglycemia (disassociation of bound insulin from antibodies) are both described as mechanisms of disease (5). These IAs are thought to be of low affinity and never lead to IR.

We present the case of a 65-year-old man with type 2 diabetes and extreme IR who was found to have IAs. The patient was never exposed to nonhuman …
Graft vs. Tumor Effects (GVT) in Non Myeloablative Stem Cells Transplant (NST) in Relapse Hodgkin Disease (HD) after Autologous Bone Marrow Transplant (ABMT).
Authors: Jorge H. Milone, Javier A. Bordone, Gustavo Kusminsky, Cecilia Foncuberta, Juan Garcia, Juliana Martinez Rolon, Eduardo Bullorsky, Cristina Dengra, Ider Cerutti
Journal: Blood (2005)
The Powered Bone Marrow Biopsy Technique Is Superior to the Standard Manual Technique for Hematologists-In-Training: A Prospective, Randomized Comparison
Authors: Louis Juden Reed, Radha Raghupathy, Marianna Strakhan, Thomas Philbeck, Mimi Y. Kim, Ramakrishna Battini, Zulfiqar Hussain, Shaad Abdullah, Sarah Schweber, Kamalesh Bala, Thomas Pacello
Journal: Blood (2011)
Treatment with Auranofin Induces Oxidative and Lethal Endoplasmic Reticulum (ER) Stress Exerting Single Agent Activity Against Primary CLL Cells
Authors: Rekha Rao, Kami Maddocks, Amy J. Johnson, Lata Chauhan, Suman Kambhampati, Siddhartha Ganguly, Ruben Reyes, Omar S. Aljitawi, Kevin Schorno, Kendra Ford, Eileen Dickman, John C. Byrd, Kapil N. Bhalla
Journal: Blood (2011)
Comprehensive Analysis of the Waldenström Macroglobulinemia “Cytokine Milieu” Reveals a Novel Role of Rantes Signaling in the Regulation of Immunoglobulin Production
Authors: Sherine F. Elsawa, Anne J. Novak, Steven C Ziesmer, Luciana L Almada, Martin E Fernandez-Zapico, Thomas E Witzig, Stephen M. Ansell
Journal: Blood (2008)
Nelarabine-Based Salvage Therapy in Adult Patients with T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (T-ALL/LL) Relapsing After Allogeneic Stem Cell Transplantation: A French Experience on Behalf of the Group for Research in Adult Lymphoblastic Leukemia (GRAAL),
Authors: Edouard Forcade, Thibaut Leguay, Norbert Vey, Andre Baruchel, Jacques Delaunay, Marie Robin, Gérard Socié, Hervé Dombret, Emmanuel Raffoux, Régis Peffault de Latour
Journal: Blood (2011)
Expression of CAMKIIγ, HSP70 and HSP90 Genes Are Differentially Associated with the Mutational Status of Tirosine Kinase Domain in Chronic Myeloid Leukemia Resistant Patients
Authors: Mariana Selena Gonzalez, Carlos Daniel De Brasi, Michele Bianchini, Cristian Ferri, Raquel Bengió, Irene Beatriz Larripa
Journal: Blood (2011)
The Heterogeneous Prognosis of Patients with Myelodysplastic Syndrome (MDS) and Chromosome 5 Abnormalities: How Does It Relate to the Original Lenalidomide Experience in MDS?.
Authors: Hagop M Kantarjian, Susan O’Brien, Farhad Ravandi, Gautam Borthakur, Stefan Faderl, Carlos Bueso-Ramos, Lynne Abruzzo, Sherry Pierce, Jianqin Shan, Jean-Pierre Issa, Guillermo Garcia-Manero
Journal: Blood (2008)
Lacrimal Gland Involvement in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome
Authors: Ana Filipa Duarte, Patricia M.S. Akaishi, Greice A. de Molfetta, Salomão Chodraui-Filho, Murilo Cintra, Alcina Toscano, Wilson Araujo Silva, Antonio A.V. Cruz
Journal: Ophthalmology (2016)
CNS Remission at the Time of Autologous Stem Cell Transplantation Improves Outcome for Patients with Non-Hodgkin's Lymphoma with Pre-Existing CNS Involvement: a CIBMTR Analysis
Authors: Richard T Maziarz, Mei-Jie Zhang, Zhiwei Wang, Ginna G. Laport, Hillard M. Lazarus, Silvia Montoto, Parameswaran Hari
Journal: Blood (2010)
Integrated Use of Minimal Residual Disease Classification and IKZF1 Alteration Status Accurately Predicts 79% of Relapses In Pediatric Acute Lymphoblastic Leukemia
Authors: Esmé Waanders, Vincent H.J. van der elden, Ellen van der Schoot, Frank N. van Leeuwen, Simon V. van Reijmersdal, Valerie de Haas, Anjo J. Veerman, Ad Geurts van Kessel, Peter M. Hoogerbrugge, Roland P. Kuiper, Jacques J.M. van Dongen
Journal: Blood (2010)
A Homoharringtonine-Based Protocol Is Superior to Daunorubicin and Idarubicin-Based Protocols in Elderly Patients with Newly-Diagnosed Acute Myeloid Leukemia with Comparable Effects and Low Toxicities: Experience in a Chinese Center.
Authors: Jianmin Wang, Shuqing Lü, Jianmin Yang, Xianmin Song, Li Chen, Jun Hou, Weiping Zhang, Chongmei Huan, Xiong Ni, Huiying Qiu
Journal: Blood (2008)
Circulating Mir-130a in Multiple Myeloma and Extramedullary Myeloma Patients
Authors: Lenka Kubiczkova-Besse, Lenka Sedlarikova, Fedor Kryukov, Lenka Radova, Jana Nekvindova, Pavel Nemec, Daniela Drandi, Simona Caltagirone, Paola Omedè, Marta Krejci, Zdenek Adam, Ludek Pour, Sabina Sevcikova, Antonio Palumbo, Mario Boccadoro, Roman Hajek
Journal: Blood (2014)
Role of Selectins in the Pathogenesis of Multiple Myeloma.
Authors: Abdel Kareem Azab, Phong Quang, Feda Azab, Costas M Pitsillides, John T Patton, Theodore Smith, Arun Sarkar, Judith M. Runnels, Aldo M. Roccaro, Antonio Sacco, Hai T. Ngo, Molly R Melhem, Patricia Maiso, Kenneth C. Anderson, Charles P. Lin, John L. Magnani, Irene M. Ghobrial
Journal: Blood (2009)
Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain
Authors: Max Ortiz-Catalan, Rannveig A Guðmundsdóttir, Morten B Kristoffersen, Alejandra Zepeda-Echavarria, Kerstin Caine-Winterberger, Katarzyna Kulbacka-Ortiz, Cathrine Widehammar, Karin Eriksson, Anita Stockselius, Christina Ragnö, Zdenka Pihlar, Helena Burger, Liselotte Hermansson
Journal: The Lancet (2016)
A Mid-Treatment FDG-Positron Emission Tomography (PET) Scan Is Highly Predictive of Subsequent Treatment Failure in Patients with Diffuse Large B-Cell Lymphoma (DLBCL).
Authors: Ashley P. Ng, Michael Lee, Annette Hogg, John F. Seymour, Henry Janusewicz, Miles Prince, Michael MacManus, Rod Hicks, Andrew Wirth
Journal: Blood (2005)
Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation
Authors: Vivek Y. Reddy, Zachary J. Malchano, Godtfred Holmvang, Ehud J. Schmidt, Andre d'Avila, Christopher Houghtaling, Raymond C. Chan, Jeremy N. Ruskin
Journal: Journal of the American College of Cardiology (2004)
An update on larynx cancer
Authors: Conor E. Steuer, Mark El‐Deiry, Jason R. Parks, Kristin A. Higgins, Nabil F. Saba
Journal: CA A Cancer Journal for Clinicians (2016)

Abstract Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common tumors of the respiratory tract. Fortunately, significant advancements have been made over the past decade in the treatment of laryngeal cancer. Although surgery has been the historical mainstay for localized disease and still is an integral part of treatment, nonsurgical options like radiation and systemic therapy have emerged as viable options. In addition, in the metastatic setting, novel agents are showing promise for this patient population. The care for patients with laryngeal cancer continues to evolve and truly requires a multidisciplinary team‐based approach. Unique morbidities, such as loss of natural voice, respiration, and airway protection during swallowing, are observed with this disease and require special consideration. CA Cancer J Clin 2017;67:31–50. © 2016 American Cancer Society.
Laser Speckle Contrast Imaging Characterizes Delayed Reperfusion After Transient Brachial Artery Occlusion in Patients with Sickle Cell Diseas
Authors: Allison K. Ikeda, Tiffany C. Anaebere, Nitin Malik, Matthew D. Antalek, Miles L. Seidel, Catherine Seamon, Alexander Gorbach, Gregory J. Kato, Hans C. Ackerman
Journal: Blood (2012)
Cytomegalovirus Infection and Lymphopenia Are Associated with Increased Mortality Post Autologous Stem Cell Transplantation
Authors: Alessandro de Moura Almeida, Erika Maria Macedo, Claudia Mac Donald Bley, Fabio R. Kerbauy, Paulo Vidal Campregher, Vicente Odone, Marinus de Moraes Lima, Jairo Sobrinho, Juliana F Fernandes, Morgani Rodrigues, Nelson Hamerschlak, Fabio P S Santos
Journal: Blood (2012)
P0010 : Fetal hepatocyte as a cell source of liver tissue engineering using a decellularized matrix
Authors: S. Ogiso, K. Fukumitsu, K. Yasuchika, J. Komori, T. Ishii, H. Katayama, T. Kawai, S. Kita, K. Yasuda, E.Y. Yoshitoshi, M. Mizumoto, S. Uemoto
Journal: Journal of Hepatology (2015)
Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine
Authors: Shathiyah Kulandavelu, Vasileios Karantalis, Julia Fritsch, Konstantinos E. Hatzistergos, Viky Y. Loescher, Frederic McCall, Bo Wang, Luiza Bagno, Samuel Golpanian, Ariel Wolf, Justin Grenet, Adam Williams, Aaron Kupin, Aaron Rosenfeld, Sadia Mohsin, Mark A. Sussman, Azorides Morales, Wayne Balkan, Joshua M. Hare
Journal: Journal of the American College of Cardiology (2016)
Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience
Authors: Jose D Sandoval-Sus, Julio C Chavez, Samir Dalia, Celeste M. Bello, Bijal D. Shah, Viet Q. Ho, Lisa Nodzon, Mohamed A. Kharfan-Dabaja, Eduardo M. Sotomayor, Lubomir Sokol, Javier Pinilla-Ibarz
Journal: Blood (2015)
Phase II Trial of Low Dose, Subcutaneous Decitabine in Myelofibrosis
Authors: Olatoyosi M Odenike, John E. Godwin, Koen Van Besien, Dezheng Huo, Dorie Sher, Patrick Burke, Scott E. Smith, Margaret Green, Julia Melnick, James L Wade, Eric P. Lester, Rebecca B. Klisovic, Maria R. Baer, Richard A Larson, Wendy Stock
Journal: Blood (2008)
Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+ T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Graft-Versus-Leukemia Response
Authors: Mike Dennis, Oliver Goodyear, Justin Loke, Nadiria Jilani, Shamyla Siddique, Gordon Ryan, Rehela Khanum, John Snowden, Michael Griffiths, Nigel H. Russell, John Yin, Charles Crawley, Gordon Cook, Paresh Vyas, Paul AH Moss, Ram Malladi, Charles F. Craddock
Journal: Blood (2011)
Liposomal Cytarabine (DepoCyte) Is Effective and Well Tolerated In Prophylaxis of Central Nervous System (CNS) Relapse of High Risk Lymphoma Patients
Authors: Wojciech Jurczak, Justyna Dzietczenia, Beata Piatkowska-Jakubas, Marcin Sobocinski, Tomasz Ogorka, Agnieszka Giza, Grzegorz Mazur, Tomasz Wrobel, Aleksander Skotnicki
Journal: Blood (2010)
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia
Authors: Lena E. Winestone, Kelly D. Getz, Tamara P. Miller, Jennifer J. Wilkes, Leah Sack, Yimei Li, Yuan‐Shung Huang, Alix E. Seif, Rochelle Bagatell, Brian T. Fisher, Andrew J. Epstein, Richard Aplenc
Journal: American Journal of Hematology (2016)

Abstract Black patients with acute myeloid leukemia (AML) experience higher mortality than White patients. We compared induction mortality, acuity of illness prior to chemotherapy, and insurance type between Black and White patients to assess whether acuity of presentation mediates the disparity. Within a retrospective cohort of 1,122 children with AML treated with two courses of standard induction chemotherapy between 2004 and 2014 in the Pediatric Health Information System (PHIS) database, the association between race (Black versus White) and inpatient mortality during induction was examined. Intensive Care Unit (ICU)‐level resource utilization during the first 72 hours following admission for initial AML chemotherapy was evaluated as a potential mediator. The total effect of race on mortality during Induction I revealed a strong association (unadjusted HR 2.75, CI: 1.18, 6.41). Black patients had a significantly higher unadjusted risk of requiring ICU‐level resources within the first 72 hours after initial presentation (17% versus 11%; RR 1.52, CI: 1.04, 2.24). Mediation analyses revealed the indirect effect of race through acuity accounted for 61% of the relative excess mortality during Induction I. Publicly insured patients experienced greater induction mortality than privately insured patients regardless of race. Black patients with AML have significantly greater risk of induction mortality and are at increased risk for requiring ICU‐level resources soon after presentation. Higher acuity amongst Black patients accounts for a substantial portion of the relative excess mortality during Induction I. Targeting factors affecting acuity of illness at presentation may lessen racial disparities in AML induction mortality.
Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era
Authors: Wendie-lou D. den Brok, Kevin W. Song, Hilary M. OLeary, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Diego Villa, Graham W. Slack, John D. Shepherd, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood (2012)
Abstract 4737: Resveratrol targeting of carcinogen-induced brain endothelial cell inflammation biomarkers MMP-9 and COX-2 is Sirt1-independent
Authors: Borhane Annabi, Simon Lord-Dufour, Amelie Vezina, Sylvie Lamy, Richard Beliveau
Journal: Cancer Research (2012)

Abstract Background: The occurrence of a functional relationship between the release of metalloproteinases (MMPs) and the expression of cyclooxygenase (COX)-2, two inducible pro-inflammatory biomarkers with important pro-angiogenic effects, has recently been inferred. While brain endothelial cells play an essential role as structural and functional components of the blood-brain barrier (BBB), increased BBB breakdown is thought to be linked to neuroinflammation. Chemopreventive mechanisms targeting both MMPs and COX-2 however remain poorly investigated. In this study, we evaluated the pharmacological targeting of Sirt1 by the diet-derived and antiinflammatory polyphenol resveratrol. Methods: Total RNA, cell lysates, and conditioned culture media from human brain microvascular endothelial cells (HBMEC) were analyzed using qRT-PCR, immunoblotting, and zymography respectively. Results: Tissue scan microarray analysis of grade I-IV brain tumours cDNA revealed increased gene expression of Sirt-1 from grade I-III but surprisingly not in grade IV brain tumours. HBMEC were treated with a combination of resveratrol and phorbol 12-myristate 13-acetate (PMA), a carcinogen known to increase MMP-9 and COX-2 through NF-κB. We found that resveratrol efficiently reversed the PMA-induced MMP-9 secretion and COX-2 expression. Gene silencing of Sirt1, a critical modulator of angiogenesis and putative target of resveratrol, did not lead to significant reversal of MMP-9 and COX-2 inhibition. Decreased resveratrol inhibitory potential of carcinogen-induced IαB phosphorylation in siSirt1-transfected HBMEC was however observed. Conclusion: Our results suggest that resveratrol may prevent BBB disruption during neuroinflammation by inhibiting MMP-9 and COX-2 and act as a pharmacological NF-κB signal transduction inhibitor independent of Sirt1. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 4737. doi:1538-7445.AM2012-4737
Obesity and Insulin Resistance after Chemotherapy in Patients with Acute Lymphoblastic Leukemia
Authors: Yesim Oymak, Belgin Uysal, Tuba Hilkay Karapinar, Yilmaz Ay, Dilek Ince, Bengu Demirag, Burcak Tatli Gunes, Esin Albudak Ozcan, Ersin Toret, Sultan Aydin Koker, Neryal Muminoglu, Canan Vergin, Korcan Demir
Journal: Blood (2014)
Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy
Authors: Yan Xu, Shuhui Deng, Gang An, Zengjun Li, Xiaoqi Qin, Weiwei Sui, Xiaoyan Feng, Dehui Zou, Lugui Qiu
Journal: Blood (2015)
Liposomal Cytarabine (DepoCyte) for Treatment of Myeloid CNS Relapse in CML Occurring during Therapy with Imatinib.
Authors: Karl J. Aichberger, Susanne Herndlhofer, Hermine Agis, Wolfgang R. Sperr, Werner Rabitsch, Harald Esterbauer, Paul Knoebl, Christian Sillaber, Ulrich Jaeger, Peter Valent
Journal: Blood (2007)
Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion
Authors: Sungkun Chun, Fei Du, Joby J Westmoreland, Seung Baek Han, Yong-Dong Wang, Donnie Eddins, Ildar T Bayazitov, Prakash Devaraju, Jing Yu, Marcia M Mellado Lagarde, Kara Anderson, Stanislav S Zakharenko
Journal: Nature Medicine (2016)
Effect of Aes-103 Anti-Sickling Agent On Oxygen Affinity and Stability of Red Blood Cells From Patients with Sickle Cell Anemia
Authors: Laurel G. Mendelsohn, Leah Pedoeim, Eduard J. van Beers, Rehan Saiyed, James S Nichols, Xunde Wang, Gregory J. Kato
Journal: Blood (2012)